The National Dexamethasone shows promise treating severe COVID-19 patients

The National Dexamethasone shows promise treating severe COVID-19 patients

Researchers in the U.K. say dexamethasone, a widely available corticosteroid, reduced COVID-19 deaths by up to one-third in severely ill hospitalized patients.

  • 2020
  • 00:03:38
  • 13-14
  • Added on: 07/03/2020
We’re sorry! Access to platform content is limited to Curio.ca subscribers. To verify if your school or institution is currently subscribed to Curio.ca, please see the Curio.ca Subscribers page.

Metadata

Subjects
COVID-19 (Disease) [LCSH] Coronavirus infections -- Treatment [LCSH] Glucocorticoids [LCSH] Science [LCSH] Medical sciences [LCSH]
Team
Christine Birak (Journalist), Andrew Chang (Host)
Closed captioning
Available
MARC Record
View Download

Can be found in

Categories